UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Abstract 19018: Histone 3 Lysine 4 Tri-Methylation is Necessary for Epicardial Epithelial-to-mesenchymal Transformation

Circulation (New York, N.Y.), 2015-11, Vol.132 (Suppl_3 Suppl 3), p.A19018-A19018

2015

Volltextzugriff (PDF)

BESPOKE IO protocol: a multicentre, prospective observational study evaluating the utility of ctDNA in guiding immunotherapy in patients with advanced solid tumours

BMJ open, 2022-05, Vol.12 (5), p.e060342-e060342

2022

Volltextzugriff (PDF)

Circulating tumor DNA (ctDNA) monitoring to inform maintenance outcomes in patients (pts) with advanced NSCLC treated with induction atezolizumab+carboplatin+nab-paclitaxel (A+CnP)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.9075-9075

2023

Volltextzugriff (PDF)

Circulating tumor DNA (ctDNA) serial analysis during progression on PD-1 blockade and later CTLA-4 rescue in patients with mismatch repair deficient metastatic colorectal cancer

Journal for immunotherapy of cancer, 2022-01, Vol.10 (1), p.e003312

2022

Volltextzugriff (PDF)

Circulating Tumor DNA Monitoring on Chemo-immunotherapy for Risk Stratification in Advanced Non-Small Cell Lung Cancer

Clinical cancer research, 2023-11, Vol.29 (22), p.4596-4605

2023

Volltextzugriff (PDF)

ctDNA Clearance and Radiographic Resolution of Disease in Response to Dual Checkpoint Inhibition in Metastatic Microsatellite Stable Colorectal Cancer with a High Tumor Mutation Burden

Case reports in oncology, 2021-06, Vol.14 (2), p.849-853

2021

Volltextzugriff (PDF)

ctDNA Clearance and Radiographic Resolution of Disease in Response to Dual Checkpoint Inhibition in Metastatic Microsatellite Stable Colorectal Cancer with a High Tumor Mutation Burden

Case reports in oncology, 2021, Vol.14 (2), p.849-853

2021

Volltextzugriff (PDF)

Early Detection of Circulating Tumor DNA Postoperatively Enables Discovery of Resectable Metastatic Disease in a Patient with Colon Cancer

Case reports in oncology, 2021, Vol.14 (3), p.1748-1753

2021

Volltextzugriff (PDF)

Early Detection of Circulating Tumor DNA Postoperatively Enables Discovery of Resectable Metastatic Disease in a Patient with Colon Cancer

Case reports in oncology, 2021-12, Vol.14 (3), p.1748-1753

2021

Volltextzugriff (PDF)

Early real-world experience monitoring circulating tumor DNA in resected early-stage non–small cell lung cancer

The Journal of thoracic and cardiovascular surgery, 2024-01

2024

Volltextzugriff (PDF)

Epicardial Epithelial-to-Mesenchymal Transition in Heart Development and Disease

Journal of clinical medicine, 2016-02, Vol.5 (2), p.27

2016

Volltextzugriff (PDF)

Histone 3 Lysine 4 Tri-Methylation in the Regulation of Epicardial Epithelial-to-Mesenchymal Transformation

Krainock, Michael R

2015

Volltextzugriff (PDF)

Longitudinal circulating tumor DNA monitoring for detection of molecular residual disease in patients with surgically resected stage II/III melanoma

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.9582-9582

2023

Volltextzugriff (PDF)

Mesenchymal and Epithelial Specific Deletion of Rac1 Prevents Lung Morphogenesis

The FASEB journal, 2016-04, Vol.30 (S1)

2016

Volltextzugriff (PDF)

Personalized, tumor‐informed, circulating tumor DNA assay for detecting minimal residual disease in non‐small cell lung cancer patients receiving curative treatments

Thoracic cancer, 2024-05, Vol.15 (13), p.1095-1102

2024

Volltextzugriff (PDF)

Prospective study of the co-relation of ctDNA with pathologic complete remission (pCR) and other efficacy outcomes in rectal cancer patients undergoing neoadjuvant chemotherapy and radiation

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.TPS235-TPS235

2022

Volltextzugriff (PDF)

Rac1 modulates mammalian lung branching morphogenesis in part through canonical Wnt signaling

American journal of physiology. Lung cellular and molecular physiology, 2016-12, Vol.311 (6), p.L1036-L1049

2016

Volltextzugriff (PDF)

Recent advancements in understanding endogenous heart regeneration—insights from adult zebrafish and neonatal mice

Seminars in cell & developmental biology, 2016-10, Vol.58, p.34-40

2016

Volltextzugriff (PDF)

Tumor-informed assessment of circulating tumor DNA and its incorporation into practice for patients with hepatobiliary cancers

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.4103-4103

2021

Volltextzugriff (PDF)

The Utility of Circulating Tumor DNA (ctDNA) Monitoring in Cancer Patients Who Are Pregnant or Planning to Become Pregnant

Case reports in obstetrics and gynecology, 2022, Vol.2022, p.9412201-9412201

2022

Volltextzugriff (PDF)

The Utility of Circulating Tumor DNA (ctDNA) Monitoring in Cancer Patients Who Are Pregnant or Planning to Become Pregnant

Case reports in obstetrics and gynecology, 2022, Vol.2022, p.9412201-5

2022

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(20)

Publikationsform

Sprache

Englisch
(22)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Abstract 19018: Histone 3 Lysine 4 Tri-Methylation is Necessary for Epicardial Epithelial-to-mesenchymal Transformation

BESPOKE IO protocol: a multicentre, prospective observational study evaluating the utility of ctDNA in guiding immunotherapy in patients with advanced solid tumours

Circulating tumor DNA (ctDNA) monitoring to inform maintenance outcomes in patients (pts) with advanced NSCLC treated with induction atezolizumab+carboplatin+nab-paclitaxel (A+CnP)

Circulating tumor DNA (ctDNA) serial analysis during progression on PD-1 blockade and later CTLA-4 rescue in patients with mismatch repair deficient metastatic colorectal cancer

Circulating Tumor DNA Monitoring on Chemo-immunotherapy for Risk Stratification in Advanced Non-Small Cell Lung Cancer

ctDNA-based detection of molecular residual disease in stage I-III non-small cell lung cancer patients treated with definitive radiotherapy

ctDNA Clearance and Radiographic Resolution of Disease in Response to Dual Checkpoint Inhibition in Metastatic Microsatellite Stable Colorectal Cancer with a High Tumor Mutation Burden

ctDNA Clearance and Radiographic Resolution of Disease in Response to Dual Checkpoint Inhibition in Metastatic Microsatellite Stable Colorectal Cancer with a High Tumor Mutation Burden

Early Detection of Circulating Tumor DNA Postoperatively Enables Discovery of Resectable Metastatic Disease in a Patient with Colon Cancer

Early Detection of Circulating Tumor DNA Postoperatively Enables Discovery of Resectable Metastatic Disease in a Patient with Colon Cancer

Early real-world experience monitoring circulating tumor DNA in resected early-stage non–small cell lung cancer

Epicardial Epithelial-to-Mesenchymal Transition in Heart Development and Disease

Histone 3 Lysine 4 Tri-Methylation in the Regulation of Epicardial Epithelial-to-Mesenchymal Transformation

Longitudinal circulating tumor DNA monitoring for detection of molecular residual disease in patients with surgically resected stage II/III melanoma

Mesenchymal and Epithelial Specific Deletion of Rac1 Prevents Lung Morphogenesis

Personalized, tumor‐informed, circulating tumor DNA assay for detecting minimal residual disease in non‐small cell lung cancer patients receiving curative treatments

Prospective study of the co-relation of ctDNA with pathologic complete remission (pCR) and other efficacy outcomes in rectal cancer patients undergoing neoadjuvant chemotherapy and radiation

Rac1 modulates mammalian lung branching morphogenesis in part through canonical Wnt signaling

Recent advancements in understanding endogenous heart regeneration—insights from adult zebrafish and neonatal mice

Tumor-informed assessment of circulating tumor DNA and its incorporation into practice for patients with hepatobiliary cancers

The Utility of Circulating Tumor DNA (ctDNA) Monitoring in Cancer Patients Who Are Pregnant or Planning to Become Pregnant

The Utility of Circulating Tumor DNA (ctDNA) Monitoring in Cancer Patients Who Are Pregnant or Planning to Become Pregnant

Suchergebnisse filtern